NCT04651868View on ClinicalTrials.gov

The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

April 27, 2021

Study Completion Date

April 27, 2021

Conditions
Gallbladder
Interventions
OTHER

GLP-2

A 210 mins intravenous infusion with GLP-2 (10 pmol × kg\^-1 × min\^-1)

OTHER

Placebo

A 210 mins intravenous infusion with isotonic NaCl

OTHER

CCK

A 180 mins intravenous infusion with cholecystokinin (0.4 pmol × kg\^-1 × min\^-1)

OTHER

Placebo

A 180 mins intravenous infusion with isotonic NaCl

Trial Locations (1)

2900

Gentofte University Hospital, Hellerup

All Listed Sponsors
collaborator

The Novo Nordisk Foundation Center for Basic Metabolic Research

OTHER

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT04651868 - The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying | Biotech Hunter | Biotech Hunter